We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
201
Costco
COST
$422B
$15.2M 0.11%
32,217
-2,547
-7% -$1.32M
DDOG icon
202
Datadog
DDOG
$89.7B
$15M 0.11%
169,448
-37,888
-18% -$3.82M
ZBRA icon
203
Zebra Technologies
ZBRA
$12.6B
$14.9M 0.1%
56,850
+11,179
+24% +$3.46M
ARWR icon
204
Arrowhead Research
ARWR
$12B
$14.8M 0.1%
448,054
+68,689
+18% +$2.77M
BCAB icon
205
BioAtla
BCAB
$5.64M
$14.7M 0.1%
38,208
+30,567
+400% +$10M
KLAC icon
206
KLA
KLAC
$266B
$14.5M 0.1%
478,130
+152,110
+47% +$5.27M
RVMD icon
207
Revolution Medicines
RVMD
$40B
$14.4M 0.1%
732,505
+177,250
+32% +$3.9M
MAA icon
208
Mid-America Apartment Communities
MAA
$15.5B
$14.3M 0.1%
92,483
+15,820
+21% +$2.72M
MTD icon
209
Mettler-Toledo International
MTD
$27B
$14.3M 0.1%
13,225
+2,830
+27% +$3.52M
ALLY icon
210
Ally Financial
ALLY
$13.3B
$14.2M 0.1%
510,885
+33,548
+7% +$1.11M
ITOS
211
DELISTED
iTeos Therapeutics
ITOS
$14.1M 0.1%
739,517
-48,134
-6% -$1.11M
SCHW
212
Charles Schwab
SCHW
$181B
$13.7M 0.1%
191,108
-289,966
-60% -$20.1M
IMGN
213
DELISTED
Immunogen Inc
IMGN
$13.6M 0.1%
2,854,635
+1,798,196
+170% +$9.48M
KROS icon
214
Keros Therapeutics
KROS
$202M
$13.6M 0.1%
361,789
MDLZ icon
215
Mondelez International
MDLZ
$77.9B
$13.4M 0.09%
243,649
+6,306
+3% +$392K
SLF icon
216
Sun Life Financial
SLF
$46B
$13.3M 0.09%
333,665
+318,990
+2,174% +$14.3M
AMBA icon
217
Ambarella
AMBA
$2.99B
$13.3M 0.09%
236,831
+226
+0.1% +$16.7K
C icon
218
Citigroup
C
$223B
$13.3M 0.09%
319,050
-176,881
-36% -$8.74M
PODD icon
219
Insulet
PODD
$11.4B
$13.2M 0.09%
57,656
+6,531
+13% +$1.64M
HES
220
DELISTED
Hess
HES
$13.2M 0.09%
121,173
-42,038
-26% -$4.66M
TREX icon
221
Trex
TREX
$4.57B
$12.9M 0.09%
293,262
+51,945
+22% +$2.78M
HPQ icon
222
HP
HPQ
$24.3B
$12.8M 0.09%
515,111
+170,589
+50% +$5.24M
BASE
223
DELISTED
Couchbase
BASE
$12.8M 0.09%
895,555
+335
+0% +$5.42K
TENB icon
224
Tenable Holdings
TENB
$3.58B
$12.5M 0.09%
360,392
+411
+0.1% +$17.2K
ZTS icon
225
Zoetis
ZTS
$32.2B
$12.4M 0.09%
83,611
+46,319
+124% +$7.74M

Similar funds

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.